Artelo Biosciences (ARTL) Profit After Tax (2014 - 2025)
Artelo Biosciences (ARTL) posted quarterly Profit After Tax of -$4.1 million for Q4 2025, down 8.28% year-over-year from -$4.5 million in Q4 2024, and down 31.88% quarter-over-quarter from -$3.1 million in Q3 2025.
Artelo Biosciences (ARTL) Profit After Tax (2014 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Profit After Tax for 12 consecutive years, with -$4.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Profit After Tax fell 8.28% year-over-year to -$4.1 million; the TTM figure through Dec 2025 stood at -$12.8 million (down 29.93% YoY), while the FY2025 annual figure was -$12.9 million, down 31.07% from the prior year.
- Profit After Tax slipped to -$4.1 million in Q4 2025 per ARTL's latest filing, from -$3.1 million in the prior quarter.
- Across five years, Profit After Tax topped out at $6.5 million in Q4 2022 and bottomed at -$7.5 million in Q3 2021.
- Historically, Profit After Tax has averaged -$2.1 million across 5 years, with a median of -$2.4 million in 2024.
- On a YoY basis, Profit After Tax climbed as much as 97.14% in 2021 and fell as far as 6612.26% in 2021.
- Artelo Biosciences' Profit After Tax stood at -$41000.0 in 2021, then jumped by 15973.17% to $6.5 million in 2022, then sank by 147.22% to -$3.1 million in 2023, then retreated by 22.94% to -$3.8 million in 2024, then retreated by 8.28% to -$4.1 million in 2025.
- Business Quant data shows ARTL's Profit After Tax at -$4.1 million in Q4 2025, -$3.1 million in Q3 2025, and -$3.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - | -4.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.09 Mn |
| Sep 30, 2025 | -3.10 Mn |
| Jun 30, 2025 | -3.22 Mn |
| Mar 31, 2025 | -2.37 Mn |
| Dec 31, 2024 | -3.78 Mn |
| Sep 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Mar 31, 2024 | -2.48 Mn |
| Dec 31, 2023 | -3.07 Mn |
| Sep 30, 2023 | -2.45 Mn |
| Jun 30, 2023 | -1.60 Mn |
| Mar 31, 2023 | -2.17 Mn |
| Dec 31, 2022 | 6.51 Mn |
| Sep 30, 2022 | -2.33 Mn |
| Jun 30, 2022 | -2.45 Mn |
| Mar 31, 2022 | -1.97 Mn |
| Nov 30, 2021 | -41,000.00 |
| Aug 31, 2021 | -7.50 Mn |
| May 31, 2021 | -2.25 Mn |
| Feb 28, 2021 | 373.00 |